XPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany
ACCESSWIRE
Rapid 25-minute point-of-care COVID-19 PCR test available for purchase in Germany commencing May 25, 2021
Volume based pricing competitive with other COVID-19 PCR test products on the market
Initial manufacturing capacity secured, additional capacity to increase based on demand
VANCOUVER, BC and MEMMINGEN, GERMANY / ACCESSWIRE / May 20, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) ('XPhyto' or the 'Company') is pleased to announce that its distribution, storage and logistics partner, Max Pharma GmbH ('Max Pharma'), will launch the sale of its 25-minute SARS-CoV-2 (COVID-19) RT-PCR test system ('Covid-ID Lab') in Germany next week. Covid-ID Lab is registered within the European Union as a commercial in vitro diagnostic (CE-IVD) test.